About this scholarly article

Clinical Activity of Sorafenib and Sunitinib in Renal Cell Carcinoma Refractory to Previous Vascular Endothelial Growth Factor–Targeted Therapy: Two Case Reports by Philip E. Shaheen; Brian I. Rini; Ronald M. Bukowski is a scholarly article available to read on EtoBox.

Author

Philip E. Shaheen; Brian I. Rini; Ronald M. Bukowski

Publisher

CIG Media Group, LP.; Elsevier ; Elsevier Inc.; Elsevier BV (ISSN 1558-7673)

Published

2006

Language

EN